How I Treat
The following information is preliminary and subject to change. All times are listed in Central time.
Caring for Women with Bleeding Disorders
Speaker:
Paula D. James, MD,FRCPC
Queen's University
Kingston, ON, Canada
DOACs Day to Day: Use of Direct Oral Anticoagulants in the Clinic
Speaker:
David A. Garcia, MD
University of Washington
Seattle, WA
DOACs in Cancer-Associated Thrombosis
Speaker:
Agnes Y. Lee, MD, MSc
University of British Columbia
Vancouver, BC, Canada
Incorporating New Sickle Cell Therapies into Clinical Practice
Speaker:
Alexis A. Thompson, MD
Northwestern University
Chicago, IL
Luspatercept for Non-Malignant Diseases
Speaker:
Maria Domenica Cappellini
Foundation IRCCS Ca' Granda Policlinico Milano - University of Milan
Milano, MI, Italy
Management and Surveillance of Genetic Predisposition to Hematologic Malignancies.
Speaker:
Lucy A. Godley
The University of Chicago
Chicago, IL
Older Patients with AML in the Setting of COVID-19
Speaker:
Alison R. Walker, MD
The Ohio State University Medical Center
Columbus, OH
Patients with CLL Who Fail Ibrutinib
Speaker:
Jacqueline C Barrientos, MD, MS
North Shore-LIJ Health System
New Hyde Park, NY
Patients with CML Who are Considering Stopping Therapy
Speaker:
Jorge E. Cortes, MD
Georgia Cancer Center Augusta University
Augusta, GA
Pediatric Patients Considering CAR T Therapy
Speaker:
Rayne H. Rouce, MD
Clinical Care Center-Texas Children's Hospital
Houston, TX
Relapsed Patients with MDS Considering Allogeneic Transplant
Speaker:
Bart L. Scott, MD
Fred Hutchinson Cancer Research Center
Seattle, WA
Storm Clouds Gathering: Cytokines and Chemokines in Clinical Practice
Speaker:
David C Fajgenbaum, MD,MBA,MSc
University of Pennsylvania
Philadelphia, PA
Update on ITP: New Guidelines and New Agents (How to Incorporate Avatrombopag & Fostamatinib)
Speaker:
Donald M. Arnold, MD, MSc
McMaster University
Hamilton, ON, Canada